Single CTC characterization to identify phenotypic and genomic heterogeneity as a mechanism of resistance to AR signaling directed therapies (AR Tx) in mCRPC patients Meeting Abstract


Authors: Scher, H. I.; Graf, R.; Louw, J.; Jendrisak, A.; Johnson, A.; Greene, S.; Rodriguez, A.; Schreiber, N. A.; McLaughlin, B.; Dugan, L.; Fleisher, M.; Lee, J.; Wang, Y.; Marrinucci, D. C.; Landers, M.; Dittamore, R. V.
Abstract Title: Single CTC characterization to identify phenotypic and genomic heterogeneity as a mechanism of resistance to AR signaling directed therapies (AR Tx) in mCRPC patients
Meeting Title: 2016 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 34
Issue: 2 Suppl.
Meeting Dates: 2016 Jan 7-9
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2016-01-10
Language: English
ACCESSION: WOS:000378109100163
PROVIDER: wos
DOI: 10.1200/jco.2016.34.2_suppl.163
Notes: Meeting Abstract: 163 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Martin Fleisher
    312 Fleisher
  2. Howard Scher
    1130 Scher
  3. Jerry Seok Lee
    3 Lee